资讯

Texas Instruments' stock is overvalued with high risks from heavy Capex, rising debt, and competition. Learn why TXN stock is ...
Inhibiting FABP5 represents a unique mechanism of action with ART26.12 standing out as a first-in-class candidate in the field of pain management. The Phase 1 Single Ascending Dose (SAD) study was ...